Abstract
Aim: To evaluate the efficacy of radiotherapy in the treatment of subfoveal classic and occult choroidal neovascularization (CNV) in age-related macular degeneration (AMD) under strict fixation control. Methods: Twenty-seven eyes of 27 patients with subfoveal CNV as a result of AMD were treated with a total dose of 20 Gy in 10fractions (10 well-defined, 17 occult). Fixation monitoring was achieved by installing a TV camera with an attached fixation light 3 cm from the cornea of the eye being treated. Visual acuity and fluorescein angiography were obtained before and 6 months after treatment. Fifteen eyes of 15 patients served as controls (4 well-defined, 11 occult).Results: After 6 months the treated group showed an average decrease in visualacuity of 27%; the control group experienced a decrease of 31%. Membrane size increased by 56% in the treated group and by 28% in the control group. There was no statistically significant difference. Within the subgroup analysis, however, patientswith classic CNV suffered significantly less visual loss than in the control group.Conclusion: Radiation therapy under optimized treatment conditions by fixation monitoring failed to control further growth in membrane size in both classic and occult CNV. Regarding visual acuity, however, patients with classic CNV seem to benefit fromradiation treatment compared to the natural course.
Similar content being viewed by others
References
Macular Photocoagulation Study Group. Argon laser photocoagulation for senile macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol 1982; 100: 912-918.
Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol 1991;109: 1220-1231.
Felten G. Ñber die Behandlung der feuchten Makula-Degeneration durch fraktionierte Röntgenbestrahlung des hinteren Augenpols. Dissertation, 1968; Medizinische Fakultät der Universität Hamburg.
Chakravarthy U, Houston RF, Archer DB. Treatment of age-related subfoveal neovascular membranes by teletherapy: a pilot study. Br J Ophthalmol 1993; 77: 265-273.
Eter N, Schüller H, Spitznas M et al. Fixation monitoring during radiation therapy for subfoveal neovascularization. Graefe's Arch Clin Exp Ophthalmol 1998; 236: 806-810.
Brady LW, Freire JE, Longton WA et al. Radiation therapy for macular degeneration: Technical considerations and preliminary results. Int J Radiat Oncol Biol Phys 1997; 39: 945-948.
Caputo G, Schwartz L, Redjimi A, Heligon J, Chauvaud D. Low dose external beam irradiation in exudative age-related macular degeneration. Vision Res 1997; 36 [Suppl]: 82.
Eter N, Schüller H, Spitznas M. Strahlentherapie zur Behandlung subfovealer choroidaler Neovaskularisationen. Ophthalmol 1997; 94: 826-831.
Martin P, Mauget M, Gérard JP et al. Radiothérapie des dégénérescences maculaires liées à l'âge (DMLA): résultats préliminaires d'une étude lyonnaise. Cancer/Radiother 1997; 1: 227-233.
Robertson DM, Buettner H, Earle J, Stafford S. External ionizing radiation therapy of macular degeneration with subfoveal choroidal neovascularizations. Proceedings of the 29th Meeting of the Retina Society, p 66, 1-6 Sept 1996, Bern, Switzerland.
Sasai K, Murata R, Mandai M et al. Radiation therapy for ocular choroidal neovascularization (phase I/Iistudy): preliminary report. Int J Radiat Oncol Biol Phys 1997; 39: 173-178.
Stalmans P, Leys A, van Limbergen E. External beam radiotherapy. 20 Gy, 2 Gy fractions fails to control the growth of choroidal neovascularization in age-related macular degeneration: a review of 111 cases. Retina 1997; 17: 481-492.
Anders N, Stahl H, Dorn A et al. Strahlentherapie der exsudativen altersabhängigen Makuladegeneration, eine prospektive kontrollierte Studie. Ophthalmol 1998; 95: 760-764.
Bergink GJ, Hoyng CB, Van der Maazen RMW et al. A randomized controlled clinical trial on the efficacy of radiation therapy in the control of subfoveal choroidal neovascularzation in age-related macular degeneration: a radiation versus observation. Graefe's Arch Clin Exp Ophthalmol 1998; 236: 321-325.
Berson AM, Finger PT, Sherr DL et al. Radiotherapy for age-related macular degeneration: preliminary results of a potentially new treatment. Int J Radiat Oncol Biol Phys 1996; 36: 861-865.
Capon M, Sarks J, Sarks S. Radiotherapy for choroidal neovascularization in age-related macular degeneration. Proceedings of the 29th Meeting of the Retina Society, p 65, 1-6 Sept 1996, Bern, Switzerland.
Donati G, Soubrane D, Quaranta M et al. Radiotherapy for isolated occult subfoveal neovascularization in age-related macular degeneration: a pilot study. Br J Ophthalmol 1999; 83: 646-651.
Freire J, Longton WA, Miyamoto CT et al. External radiotherapy in macular degeneration: technique and preliminary subjective response. Int J Radiat Oncol Biol Phys 1996; 36: 857-860.
Friedrichsen EJ, Slater JD, Loredo LN et al. Proton beam irradiation of subfoveal choroidal neovascularization in age-related macular degeneration. Invest Ophthalmol Vis Sci 1995; 36 [Suppl]: 224.
Haas A, Pakisch B, Langmann G et al. Fraktionierte Teletherapie bei seniler Makuladegeneration. Spekt Augenheilkd 1997; 11: 96-99.
Hart PM, Chakravarthy U, Makenzie G et al. Teletherapy for subfoveal choroidal neovascularization of age-related macular degeneration: results of follow up in a non-randomised study. Br J Ophthalmol 1996; 80: 1046-1050.
Holz FG, Engenhart R, Bellmann C et al. Stereotactic radiation therapy for sub-foveal choroidal neovascularization secondary to age-related macular degeneration. In: Wiegel T, Bornfeld N, Foerster MH, Hinkelbein W (eds): Radiotherapy of ocular disease. Front Radiat Ther Oncol, Basel, Karger, 1997; 30: 238-246.
Kobayashi H, Kobayashi K. Age-related macular degeneration: long-term results of radiotherapy for subfoveal neovascular membranes. Am J Ophthalmol 2000; 130: 617-635.
Krott R, Staar S, Müller R-P et al. Radiatio ab externo als Therapie für die exsudative altersabhängige Makula-Degeneration-Eine 'Matched Pairs' Studie. Proc of DOG Symposium, Berlin, 1997; (K 384) S 126.
Mandai M, Matsuda N, Miyamoto H et al. Long term effects of low-dose radiation therapy on subfoveal choroidal neovascularization in age-related macular degeneration. Invest Ophthalmol Vis Sci 1997; 38: 93.
Marcus D, Sheils C, Burch S et al. The radiation of age-related macular degeneration (ROARMD) study. Invest Ophthalmol Vis Sci 1996; 37 [Suppl]: 224.
Mendelsohn M, Spaide RF, Abramson DH, Yannuzzi LA.. Radiation therapy for wet macular degeneration. Ophthalmology 1995; 102 [Suppl]: 94.
RAD Study Group. A prospective, randomized, double-masked trial on radiation therapy for neovascular age-related macular degeneration. Ophthalmology 1999; 106: 2239-2247.
Schleicher UM, Adreopoulos D, Wolf S et al. Radiotherapy of macular degeneration. Experience with Two Fractionation Schemes. In: Wiegel T, Bronfeld N, Foerster MH, Hinkelbein W (eds): Radiotherapy of Ocular Disease, Front Radiat Ther Oncol, Basel, Karger, 1997; 30: 253-258.
Spaide RF, Guyer DR, McCormick B et al. External beam radiation therapy for choroidal neovascularization. Ophthalmology 1997; 105: 24-30.
Thölen AM, Meister A, Bernasconi P, Messmer EP. Radiotherapie von subretinalen Neovaskularisationsmembranen bei altersabhängiger Makuladegeneration (AMD). Ophthalmol 1998; 95:691-698.
Thölen AM, Meister A, Bernasconi P, Messmer EP. Radiotherapie von choroidalen Neovaskularisationen (CNV) bei altersabhängiger Makuladegeneration (AMD). Klin Monatsbl Augenheilkd 2000; 216: 112-115.
Valmaggia C, Bischoff P, Ries G. Niedrig dosierte Radiotherapie der subfoveolären Neovaskularisationen bei altersabhängiger Makuladegeneration. Vorläufige Resultate. Klin Monatsbl Augenheilkd 1995; 206:343-346.
Zografos L, Egger E, Piguet B. Proton beam irradiation in age-related macular degeneration. Vision Res 1996; 36 [Suppl]: 83.
Eter N, Wegener A, Schüller H, Spitznas M. Radiotherapy for age-related macular degeneration causes transient lens-transparency changes. Br J Ophthalmol 2000; 84: 757-760.
TAP-Study Group. Photodynamic therapy of choroidal neovascularization in age-related macular degeneration with Verteporfin, one-year results of 2 randomized clinical trials-TAP report 1.-Arch Ophthalmol 1999; 117: 1329-1345.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Eter, N., Schüller, H. & Spitznas, M. Radiotherapy for age-related macular degeneration: Is there a benefit for classic CNV?. Int Ophthalmol 24, 13–19 (2001). https://doi.org/10.1023/A:1014445524293
Issue Date:
DOI: https://doi.org/10.1023/A:1014445524293